KM plotter analysis showed a significant correlation between high ARSD expression level and the favorable overall survival (OS) (with the HR of 0.66, p = 0.0082), relapse-free survival (RFS) (HR of 0.69, p = 1.7-e6), and progression-free survival (PFS) (HR of 0.63, p = 0.01) in BC patients (Fig. 1H). Here, ARSD is linked to breast cancer.